| Reason |
Number of studies |
| Sanofi is not the sponsor or does not have legal right to share
|
14 |
| Product development ongoing
|
3
|
| Product with ongoing regulatory activities
|
7
|
| Requested data not patient-level data or clinical documents |
3
|
| Requested data not collected in English |
2
|
| Requested information already publicly available |
2
|
| High risk of re-identification |
37
|
| Study not completed or not yet accepted for publication |
3
|
| Data not available due to the age of the study |
1
|
| Patent/ Litigation related reason |
5
|
| Proposal number
|
Study Sponsor(s)/funder(s)
|
Reason(s)
|
| 615 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 618 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 633 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 690 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 931 |
BI/GSK |
The Research Proposal did not meet the Sponsor
policies for informed consent |
| 938 |
BI/GSK/Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
| 941 |
Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
| 1047 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 1087 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 1107 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
| 1552 |
Novartis |
The proposed research required data that was not collected in the studies requested |
| 1235 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
| 1245 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
| 1589 |
Novartis |
The Research Proposal is not seeking access to anonymised patient level data |
Just a moment, the page is loading...